Today: 20 May 2026
P&G stock drops nearly 1% as TD Cowen downgrades; investors weigh tariffs and a new Wonderbelly buy
28 January 2026
2 mins read

P&G stock drops nearly 1% as TD Cowen downgrades; investors weigh tariffs and a new Wonderbelly buy

New York, Jan 28, 2026, 3:02 PM EST — Regular session

  • Procter & Gamble shares dropped roughly 1% in afternoon trading, following a wider slump across consumer staples.
  • TD Cowen downgraded P&G to “Hold,” citing a sluggish recovery driven by weakening pricing power and increased promotions.
  • P&G spotlights a Wonderbelly buy and a fresh Crest toothpaste rollout, but rate shifts steal the spotlight.

Procter & Gamble shares dropped almost 1% Wednesday afternoon, slipping alongside broader consumer staples weakness and a new brokerage downgrade weighing on the stock. It hit a low of $146.88 before settling down 1.0% at $146.89.

The pullback is significant since P&G is a textbook “defensive” stock — known for steady demand, strong brands, and consistent cash payouts. Investors tend to favor it when growth wobbles. But as Treasury yields climb, these dividend-focused shares often lose some shine, with bonds providing tougher competition.

The timing coincides with a fierce debate over pricing power and how fast consumers shift to cheaper options when discounts pop up. For P&G, this strikes at the core — diapers, detergent, and paper products.

TD Cowen cut its rating on the Tide and Pampers maker to “Hold” from “Buy,” but raised the price target to $156. The firm now expects the recovery to be slower than anticipated, with muted pricing and a heavier reliance on promotions. It projects roughly 2% “organic” sales growth—excluding currency effects and acquisitions—for fiscal years 2026 and 2027. TD Cowen also noted recent share losses and intensified promotional activity in several categories. Investing.com

The company is pushing to expand its health segment amid efforts to boost growth in its main aisles. On Jan. 26, P&G announced in a blog post that Wonderbelly — a “free-from” digestive wellness brand — has been added to its Personal Health Care lineup, joining names like Metamucil and Pepto-Bismol. “Bringing Wonderbelly into the PHC digestive wellness portfolio complements our existing brands,” said Phil McWaters, senior vice president at P&G Personal Health Care. Procter & Gamble

Crest, a major player in P&G’s oral-care lineup, launched a new “Clean Breath” toothpaste this week. The product targets odor-causing bacteria and is designed for daily use. “We know consumers are frustrated by having to continually fight against bad breath,” said Dr. Svetlana Farrell, Oral Care, North America at Procter & Gamble, in the company’s announcement. Business Wire

A regulatory filing provided fresh insight for investors. According to a Form 4, Chief Brand Officer Marc S. Pritchard exercised options and offloaded 95,903 shares, with the transaction logged at a weighted average price near $151.15 each.

Tariffs continue to weigh on margins and pricing strategies. Reuters reported this week that P&G has bumped prices in the U.S. by about 2% to 2.5% to counter tariff expenses and sluggish sales, while posting its fifth consecutive quarterly margin decline. “Most consumers are still mad about the level of current prices and won’t take kindly to further hikes,” said Brian Jacobsen, chief economic strategist at Annex Wealth Management. Reuters

The macro environment offered little relief. On Wednesday, the Federal Reserve kept rates unchanged and highlighted “elevated” inflation in its latest policy update, putting bond yields under the spotlight for sectors reliant on steady cash flow and dividends. Reuters

In the consumer sector, investors are weighing “resilient demand” against “more discounting.” Kimberly-Clark, a key competitor in diapers and tissues, posted better-than-expected profits just a day earlier, driven by cost reductions and steady essentials demand — highlighting how execution and price/mix currently play a crucial role in staples. Reuters

The downside risk for P&G is well-known: if promotions ramp up to hold shelf space and volume, margins could shrink fast—especially if tariff expenses or other input costs remain high. A weaker consumer, especially among price-conscious families, would only make that squeeze tougher.

Traders will be eyeing broader market moves after hours, with Microsoft and Meta set to report earnings Wednesday. Alphabet and Amazon follow next week. They’ll also watch whether staples can maintain prices without sacrificing much volume.

Stock Market Today

  • Stocks Added to Zacks Strong Sell List on May 20th: BRCC, CVE, MITT
    May 20, 2026, 5:27 AM EDT. Three stocks joined the Zacks Rank #5 (Strong Sell) list on May 20th. BRC Inc. (BRCC), a coffee and apparel seller, saw its current year earnings estimate cut by 33.3%. Cenovus Energy Inc. (CVE), an oil and gas producer, had its earnings forecast lowered by 24.5%. AG Mortgage Investment Trust (MITT), a residential mortgage REIT, faced a 17.5% earnings revision downward. These revisions reflect growing bearish sentiment as analysts adjust expectations. The Zacks Rank #5 indicates a strong sell recommendation based on recent downward earnings revisions over 60 days.

Latest articles

Wall Street Puts $150 Target on Intel in AI Push

Wall Street Puts $150 Target on Intel in AI Push

20 May 2026
Intel shares rose 2.43% to $110.80 on Tuesday, ending a five-day losing streak. The stock rebounded as analysts raised price targets, citing demand for AI server CPUs. Intel traded between $102.40 and $113.07 during the session. The Nasdaq Composite fell 0.84%, with Nvidia and AMD also down.
Marvell shares active as earnings approach, AI chip focus in view

Marvell shares active as earnings approach, AI chip focus in view

20 May 2026
Marvell Technology shares rose 4.53% to $184.25 in premarket trading Wednesday, extending Tuesday’s 4.35% gain. The company will report fiscal Q1 2027 results after the close on May 27. Analysts at Evercore ISI, Melius Research, and CLSA raised price targets, citing strong demand for custom AI chips. Marvell posted record fiscal 2026 revenue of $8.195 billion in March.
SpaceX restarts Starlink launches after satellite mishap — and another Falcon 9 is already queued

SpaceX IPO Moves Closer as Goldman Nears Top Role in $1.75 Trillion Listing

20 May 2026
Goldman Sachs is set to lead SpaceX’s planned IPO, which could become the largest in history, with a targeted valuation of about $1.75 trillion, Reuters reported. SpaceX aims to publish its prospectus as soon as Wednesday and list on Nasdaq under the ticker SPCX as early as June 12. The company’s next Starship test flight is scheduled for May 21 from Texas. Morgan Stanley, Bank of America, Citigroup, and JPMorgan are also expected to play major roles.
Gilead stock dips as Medicare targets Biktarvy for 2028 price talks — and Trodelvy gets a guideline lift
Previous Story

Gilead stock dips as Medicare targets Biktarvy for 2028 price talks — and Trodelvy gets a guideline lift

Bank of America stock slips after Fed holds rates: what traders watch next for BAC
Next Story

Bank of America stock slips after Fed holds rates: what traders watch next for BAC

Go toTop